Amphastar Pharmaceuticals, Inc. Share Repurchase Authorization
Amphastar Pharmaceuticals, Inc. (AMPH) had Share Repurchase Authorization of $285.00 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-05-10
- 2024-03-31: Stock Repurchase Program, Authorized Amount $285.00M.
- 2023-12-31: Stock Repurchase Program, Authorized Amount $285.00M.
- 2023-03-31: Stock Repurchase Program, Authorized Amount $235.00M.
- 2022-12-31: Stock Repurchase Program, Authorized Amount $235.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2024-03-31 | $285.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $285.00M 10-K · filed 2024-02-29 |
| 2023-03-31 | $235.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $235.00M 10-K · filed 2023-03-01 |
| 2021-12-31 | $160.00M 10-K · filed 2022-03-11 |
| 2020-12-31 | $140.00M 10-K · filed 2021-03-15 |
| 2015-11-10 | $10.00M 10-K · filed 2016-03-15 |
| 2014-11-06 | $10.00M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |